FIELD: medicine.
SUBSTANCE: invention relates to a method for cell preservation. For in vitro or ex vivo preservation of animal cells, preferably human, stage of holding the above cells with moderate hypothermia in a hypoxic and/or hypercapnic environment for 12 to 72 hours to their preservation with deep hypothermia.
EFFECT: invention allows to increase cell survival and ability to proliferation.
18 cl, 5 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTABLE PRESERVATIVE MEDIUM FOR PRESERVING PLACENTAL BLOOD CELLS, BONE MARROW AND PERIPHERAL BLOOD | 2016 |
|
RU2727643C2 |
| METHOD FOR CORD BLOOD MONONUCLEAR CELLS (cbMNC) EXPANSION ex vivo IN PRESENCE OF MULTIPOTENT MESENCHYMAL STROMAL CELLS (MMSCS) | 2013 |
|
RU2525143C1 |
| METHOD OF REPRODUCING HUMAN MESENCHIMAL STROMAL CELL CULTURES RECOVERED FROM LIPOASPIRATE | 2007 |
|
RU2351649C1 |
| 3D IN VITRO TWO-PHASE OSTEOCHONDRAL CONSTRUCT | 2013 |
|
RU2615439C2 |
| COLONY FORMATION MEDIUM AND ITS APPLICATION | 2017 |
|
RU2756561C2 |
| METHOD FOR EVALUATING AND MONITORING IN VITRO PURITY OF A CELL PREPARATION, USE OF A GROWTH FACTOR, A KIT | 2016 |
|
RU2738969C2 |
| REPROGRAMMING HUMAN ENDOTHELIUM IN HEMATOPOIETIC PRECURSORS OF MULTIPLE LINES OF DIFFERENTIATION USING CERTAIN FACTORS | 2014 |
|
RU2691062C2 |
| COMPOSITION INHIBITING MEIS PROTEINS | 2017 |
|
RU2755212C2 |
| LENTIVIRAL VECTORS PSEUDOTYPED BY MUTANT BaEV GLYCOPROTEINS | 2012 |
|
RU2618864C2 |
| METHOD FOR OBTAINING OF MSC-ASSOCIATED NON-DIFFERENTIATED HEMOPOIETIC PRECURSOR CELLS WITH CD34+/CD133+ PHENOTYPE | 2016 |
|
RU2628092C1 |
